Señales en vivo de VCEL | Maximiza tus Ganancias con Getagraph.com

VENDER 112045 min ago

@ $47.14

Emitido: 14 feb 2024 @ 12:51

Retorno: -0.13%

Señal anterior: feb 13 - 09:30

Señal anterior: Comprar

Retorno: 5.65 %

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 16:00):

Stats
Volumen de hoy	454 722
Volumen promedio	428 539
Capitalización de mercado	2.28B
EPS	$0 ( 2024-02-29 )
Próxima fecha de ganancias	( $-0.110 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-672.57
ATR14	$0.108 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Colangelo Dominick	Buy	6 002	Stock Option (Right to Buy)
2024-04-30	Colangelo Dominick	Buy	13 888	Stock Option (Right to Buy)
2024-04-30	Colangelo Dominick	Buy	5 555	Common Stock
2024-04-30	Colangelo Dominick	Buy	5 555	Stock Option (Right to Buy)
2024-04-30	Colangelo Dominick	Buy	6 002	Common Stock

INSIDER POWER
68.00
Last 100 transactions
Buy: 883 338 \| Sell: 166 323

Volumen Correlación

Largo: -0.07 (neutral)

Corto: -0.56 (weak negative)

Signal:(25.467) Neutral

Vericel Corp Correlación

10 Correlaciones Más Positivas
CSLMU	0.902
CLBT	0.89
ATCX	0.885
BRACU	0.885
CRVL	0.875
CMPO	0.872
ARAY	0.871
CVT	0.866
BYNOU	0.865
EYEN	0.865

10 Correlaciones Más Negativas
NAKD	-0.887
TRIT	-0.884
PRPH	-0.88
VIEW	-0.871
RAVN	-0.868
LAWS	-0.86
CHKEL	-0.859
SYBT	-0.856
PROC	-0.855
HTBK	-0.855

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vericel Corp Correlación - Moneda/Commodity

0.13
( neutral )

0.34
( neutral )

-0.70
( moderate negative )

-0.50
( neutral )

0.49
( neutral )

0.18
( neutral )

Vericel Corp Finanzas

Annual	2023
Ingresos:	$197.52M
Beneficio Bruto:	$135.58M (68.64 %)
EPS:	$-0.0669

FY	2023
Ingresos:	$197.52M
Beneficio Bruto:	$135.58M (68.64 %)
EPS:	$-0.0669

FY	2022
Ingresos:	$164.37M
Beneficio Bruto:	$109.79M (66.80 %)
EPS:	$-0.350

FY	2021
Ingresos:	$156.18M
Beneficio Bruto:	$106.03M (67.88 %)
EPS:	$-0.160

Financial Reports:

No articles found.

Vericel Corp

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.